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Background: Despite the advances in the treatment of obstructive sleep apnea (OSA) with mandibular advance-
ment appliances (MAA), their effectiveness is dependent on the patients’ compliance. Our aims were to evaluate 
the long-term adherence to MAA therapy and patients’ experiences of the treatment in OSA.
Material and Methods: Sixty-nine patients (52 males, 17 females; Mean age: 54.4±10.8 years) were included in the 
study. The subjects were mild (56%) and moderate (44%) OSA patients who had been treated using MAA at least 
4 years prior to the study. A phone survey was used to determine the demographic characteristics of the patients, 
as well as to assess self-reported adherence to therapy, subjective long-term effectiveness, and patient experiences 
with the appliance. Descriptive statistics, Pearson Chi-square test, and independent samples t-test were used for 
data analysis. 
Results: Only 22 (32%) patients reported using the appliance regularly. Most of the non-adherent patients had 
stopped using their appliances in the first year (55%). The mean duration of appliance use was 33.5 months (Me-
dian: 12 months). No significant differences in appliance type, OSA severity, educational level, gender, marital 
status, income status, employment status or place of residence existed between adherent and non-adherent sub-
jects. Adherent subjects were significantly younger than non-adherent subjects (Age: 50.6 ± 11.9 versus 56.1 ± 9.9, 
p < 0.05). The  most common reasons reported by patients were inability to adapt to the appliance (62%) and pain 
in the temporomandibular joint (38%). The most common factors associated with continued usage were effective-
ness (100%) and ease of use (64%). 
Conclusions: The overall long-term nonadherence to MAA therapy in mild-to moderate OSA patients was high 
suggesting that barriers to MAA therapy adherence should be prevented to increase the efficiency of oral appli-
ance treatment in OSA and achieve better outcomes for this disease.
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Introduction
Obstructive sleep apnea (OSA) is a highly prevalent 
sleep-related breathing disorder characterized by periods 
of recurrent cessation of breathing caused by partial or 
complete collapse of the upper airway. Untreated OSA is 
associated with cardiovascular disorders, cerebrovascular 
disease, and cognitive dysfunction (1). The gold standard 
treatment for OSA is continuous positive airway pressure 
(CPAP) therapy to prevent upper airway collapse during 
sleep. However, adherence to CPAP is often poor, which 
limits its efficacy (2). Other treatment alternatives include 
oral appliances (OA), various surgeries and/or adjunctive 
measures such as weight loss (1). 
Mandibular advancement appliances (MAA) act by 
protruding the mandible and increasing the upper air-
way size and they are the most commonly used type of 
OA’s in the treatment of OSA (3). Their use is indicated 
in patients with mild to moderate OSA, and in individu-
als who are intolerant to CPAP treatment (4). They have 
been shown to be effective in reducing snoring and ob-
structive breathing events as well as improving health 
outcomes in the short-term (5). Long-term studies have 
also reported continuing effectiveness in terms of Ap-
nea-Hypopnea Index (AHI) and Oxygen Desaturation 
Index (ODI) up to 5 years (6-8), while others have found 
that AHI increases with time (9,10). Comparative stud-
ies show that most patients prefer oral appliances over 
CPAP (5,11,12).
Despite the advances in the treatment of sleep apnea 
with oral appliances, their effectiveness is dependent on 
the patients’ adherence. Adherence to a medical regi-
men is defined as the successful adoption of a treatment 
program (13). According to the World Health Organi-
zation (WHO), 50% of patients with chronic diseases 
do not follow treatment recommendations (14). Long-
term compliance studies with oral appliances ranging 
in follow-up durations from 1 to 10 years report a wide 
range of adherence between 4-90% (8,15). Therefore, 
our aims in this study were to evaluate the long-term 
adherence rates to MAA therapy and patients’ reported 
experiences of the treatment. 
Material and Methods
After obtaining the institutional ethics committee ap-
proval, 77 patients (60 males, 17 females) who were suc-
cessfully treated with an MAA at our clinic between 
2005 and 2012 (at least 4 years prior to the study) were 
contacted by phone. These patients had been diagnosed 
with sleep apnea at the Department of Otorhinolaryn-
gology or the Department of Chest Diseases using an 
overnight polysomnography. Their disease severity had 
been classified as mild (AHI ≥ 5 and < 15, n=46) or 
moderate (AHI ≥ 15 and < 30, n=31) (16),  and they have 
been referred to our clinic for treatment with an OA. 
Two different appliance designs had been used in the 
treatment of patients. One group (n=52) had been fit-
ted with the monobloc appliance, and the second group 
(n=25) with a modified twin-block appliance (17). Ef-
ficacy of the oral appliance had been determined by an 
overnight polysomnography during which the patients 
wore their appliances. The treatment had been consid-
ered successful if there was a reduction in AHI to < 
5 events per hour with a > 50% resuction in baseline 
AHI.
A phone survey was used to determine the demographic 
characteristics of the patients, as well as to assess self-
reported adherence to therapy, subjective long-term ef-
fectiveness, and patient experiences with the appliance. 
Patients who stopped using their appliances were clas-
sified as ‘’non-adherent’’, while those who were still us-
ing their MAA’s were classified as ‘’adherent’’. 
-Statistical analysis
Statistical analyses were performed using SPSS, Ver-
sion 21.0 (IBM SPSS Statistics for Windows, Version 
21.0. Armonk, NY: IBM Corp.). Demographic data were 
analyzed using descriptive statistics which included the 
mean, standard deviation and percentage distribution. 
Categorical variables were compared between adher-
ent and non-adherent groups using Pearson Chi-square 
test. For continuous variables independent samples t-
test was used. Statistical significance was defined as  p 
< .05 (two-tailed). 
Results
Demographic characteristics of the patients are pre-
sented in Table 1. Out of the initial 77 patients, we 
were able to reach 69 (90%) by phone. All of the pa-
tients verbally consented to answer the questionnaire. 
The patients included in the study were treated with 
either a Monobloc (n=47 (68%)) or a Modified Twin-
block Appliance (n=22 (32%)). The responding group 
consisted of 39 patients (56%) with mild OSA and 30 
patients (44%) with moderate OSA. The mean age of 
the sample was 54.4±10.8 years (54±11.4 years in males; 
55.6±8.2 years in females), with the range of ages vary-
ing from 29 years to 76 years old.  Most of the patients 
were male (75%), married (96%), currently employed 
(56%), lived in an urban area (94%), had an educational 
level of high school or higher (83%), and reported me-
dium income (59%). The majority of respondents com-
mented that their appliance was successful in decreas-
ing their symptoms (74%), comfortable to use (58%), 
and easy to maintain (88%). Seventy per cent of those 
interviewed replied that they would recommend oral 
appliance therapy to their friends. ‘’Difficulty of use’’ 
was the most commonly cited reason (n=12; 60%) by 
those who wouldn’t recommend the treatment, followed 
by ‘’ineffectiveness’’ (n=7; 35%). 
Only 22 (32%) subjects reported using the appliance 
regularly. Most of the non-adherent patients had stopped 









Mean ± SD (Min-Max)
  Age-years 54.4.1±10.8(29-76) 50.6±11.9(29-69) 56.1±9.9(30-76) 0.046**
Number (%)
  Monobloc appliance 47(68) 14(64) 33(70) 0.584
  Mild OSA 39(56) 13(59) 26(55) 0.810
  High school graduate or 
  higher 
57(83) 18(82) 39(83) 0.618
  Male 52(75) 17(77) 35(74) 0.801
  Married 66(96) 21(95) 45(96) 0.956
  Income status 
      High 20(29) 9(41) 11(23)
0.252      Medium 41(59) 10(45) 31(66)
      Low 8(12) 3(14) 5(11)
Currently employed 39(56) 12(54) 27(57) 0.942
Lives in urban area 65(94) 20(91) 45(96) 0.381
Table 1: Demographic characteristics of the patients.
SD, standard deviation; Min, minimum; Max, maximum
* Comparative statistics (Adherent vs. Non-adherent) and respective p values. 
were obtained using Pearson Chi-square for categorical variables and indepen-
dent samples t-test for continuous variables. Statistical significance was defined 
as p < .05 (two-tailed).
** Statistically significant.
using their appliances in the first year (55%), 10% in the 
second year and another 15% in the fourth year (Fig. 1). 
The mean duration of appliance use was 33.5 months 
(Median: 12 months; Range: 1-132 months). No signifi-
cant differences in appliance type, OSA severity, edu-
cational level, gender, marital status, income status, em-
ployment status or place of residence existed between 
adherent and non-adherent subjects. Adherent subjects 
were significantly younger than non-adherent subjects 
(Age: 50.6 ± 11.9 versus 56.1 ± 9.9, p < .05).
The reasons given for stopping appliance use are shown 
in Table 2. The  most common reasons reported by pa-
tients were inability to adapt to the appliance (62%), 
pain in the temporomandibular joint (38%), ineffective-
ness in decreasing symptoms (28%), and dry mouth 
(28%). As shown in Table 3, the factors associated with 
continued usage were effectiveness (100%), ease of use 
(64%), support from their partner (32%), the shame 
caused by disease symptoms (32%), and portability of 
the appliance (27%).
Only 38% of the non-adherent subjects seeked other 
treatments for their OSA. Of these patients, 50% were 
using CPAP and 31% had undergone upper airway sur-
gery (Table 4).
Fig. 1: Reported years of appliance use in non-adherent pa-
tients (y; years).
Discussion
This study aimed to determine adherence to treatment 
and long-term MAA experience in a group of patients 
in a university clinic. A phone survey was preferred 
because the response rate of telephone follow-up is re-
ported to be higher (18). We were unable to contact 8 
patients, possibly due to changes in phone number or an 
unwillingness to answer a call from an unknown num-
Med Oral Patol Oral Cir Bucal. 2018 Jan 1;23 (1):e72-7.                                                                                                                                           Oral appliance therapy in obstructive sleep apnea
e75
Reasons Frequency of reason*
     Inability to adapt n=29     (62%)
     Pain in temporomandibular 
joint
n=18     (38%)
     Ineffectiveness n=13     (28%)
     Dry mouth n=13     (28%)
     Increased saliva n=9       (19%)
     Changes in occlusion n=8       (17%)
     Increase in disease severity n=5       (11%)
     Lack of retention     n=5       (11%)
     Halitosis n=4        (8%)
     Hard to clean n=2        (4%)
     Loss of appliance    n=2        (4%)
     Breakage    n=0        (0%)
Table 2: Self-reported reasons for stopping appliance use.
* In some cases,patients cited more than 1 reason.
Factors Frequency of factor*
     Effectiveness n=22     (100%)
     Ease of use n=14     (64%)
     Support from partner n=7       (32%)
     Shame caused by symptoms n=7       (32%)
     Portability n=6       (27%)
Table 3: Self-reported factors associated with continued usage.
* In some cases,patients cited more than 1 factor.
Treatment type Frequency*
     CPAP n=13     (50%)
     Upper airway surgeries n=8       (31%)
     Weight loss n=3       (11%)
     Sleep position change n=2       (8%)
     Nasal strips and boil-and-bite MAA n=1       (4%)
Table 4: Treatment types in non-adherent patients who received 
further treatments (n=26).
* One patient reported receiving more than 1 treatment.
ber. However, all the patients that we were able to reach 
consented to answer the survey which resulted in a high 
response rate. 
Lack of adherence to therapy is a well-recognized prob-
lem in chronic conditions and results in potentially 
avoidable health risks as well as unnecessary health 
care spending (19). Studies show that adherence rates 
in MAA treatment are also suboptimal. In a systematic 
review, Hoffstein (15) reported a wide range of (4-76%) 
compliance rates in the first year of appliance use. Other 
studies found that adherence decreased with time: 83% 
after 1 year (20), and 62-64% after 4-6 years (10,21). 
Our findings demonstrated an adherence rate of 32% 
in long-term (4-11 years) MAA therapy of mild-to-
moderate OSA patients. Adherence in the current study 
was also lower than the 60% compliance rate reported 
in a 10-year study by Wiman Eriksson et al. (8). Access 
to healthcare, cultural beliefs, education about chronic 
disease, and the nature of patient-physician interactions 
may vary between countries (22) which could have been 
a contributing factor to the low compliance rate in our 
study.
However, even the patients who were not using their 
appliances were willing to recommend MAA therapy 
to a friend, which is in aggreement with the findings 
of Nordin et al. (23). Consistent with the results of de 
Almeida et al. (21), we found that the highest percent-
age of  dropouts (55%) occurred in the first year of ap-
pliance use. This pattern of withdrawal from therapy 
can also be found in CPAP adherence studies (24).   
The major reasons for discontinuation of MAA therapy 
in our study were inability to adapt to the appliance, 
pain in the temporomandibular joint, ineffectiveness in 
decreasing symptoms, and dry mouth. Similarly, exces-
sive salivation, xerostomia, tooth and gingival discom-
fort, and self-appreciated lack of efficacy are the most 
common side effects reported in literature (6,15,21,23). 
There were also facilitators associated with continued 
usage such as effectiveness, ease of use, support from 
their partner, the shame caused by disease symptoms, 
and portability of the appliance. These results empha-
size the need for a good communication between the 
clinician, the patient and their family. The patients’ 
complaints should be adressed by the dentist, and they 
should be informed that the side effects are temporary 
in many cases (15). Furthermore, incorporating educa-
tional, technological, psychosocial or multi-dimensional 
strategies that have been tested in CPAP adherence may 
also help in increasing the long-term adherence rates in 
oral appliance therapy (25).
Most of the patients in our study (68%) were treated 
with a monobloc appliance, which was the most fre-
quent type of MAA at the time. Some studies report 
that monobloc appliances are as effective as bibloc ap-
pliances although the effect remains uncertain (26). Pa-
tient satisfaction has also been found to be comparable 
for these different appliance types (23). Dieltjens et al. 
(27) found that MAA type was a predictor of treatment 
discontinuation, with an odds ratio of 9.12 with mono-
bloc MAA leading to a higher discontinuation rate 
compared to bibloc appliances. In contrast with these 
Med Oral Patol Oral Cir Bucal. 2018 Jan 1;23 (1):e72-7.                                                                                                                                           Oral appliance therapy in obstructive sleep apnea
e76
results, we found no significant differences in appliance 
type between groups. There were also no differences in 
OSA severity, educational level, gender, marital status, 
income status, employment status or place of residence. 
The only predictor for adherence in our study was age. 
The effect of age on oral appliance adherence is contro-
versial. Carballo et al. (28)  found that adherence among 
older adults was lower, whereas Dieltjens et al. (27) have 
noted no association between these two variables. We 
found that adherent subjects were significantly younger 
than non-adherent subjects. One possible reason for 
these conflicting results is the differences in age groups 
between the study populations. Another explanation 
could be that any reduced adherence noted as a function 
of advancing age may be mediated by other factors such 
as changes in the dentition or the mucosal tissue making 
it harder for older patients to adapt to oral appliances. 
Further studies with larger samples that include all age 
groups is needed for better understanding the role of age 
in oral appliance therapy.
Almeida et al. (21) reported that 23% of moderate-to-
severe OSA patients non-adherent to MAA therapy 
use CPAP after stopping oral appliance use. Similarly, 
McGown et al. (29) found that 14% of patients choose to 
use CPAP after trying MAA therapy.  Consistent with 
these previous studies, we determined that 50% of the 
non-adherent subjects who seeked other treatments for 
their OSA were using CPAP. 
Our research has some limitations. The first one is the 
use of subjective compliance data to determine adher-
ence rates. Despite the limitations of this method, it is 
still commonly used in adherence studies. Furthermore, 
a high agreement between objective and subjective 
compliance data in oral appliance therapy has been re-
ported in literature (16). Nevertheless, social desirabil-
ity response bias and recall bias cannot be totally ruled 
out, especially in long-term survey studies. Another 
major limitation is the sample size of the group. Since 
this was a single-center study with long-term follow-up 
we failed to include a higher number of patients. Thus, 
future research would benefit from multi-center studies 
with larger sample sizes to increase the generalizability 
of the findings and objective compliance data which can 
be gathered by using the newly developed compliance 
monitors embedded within the appliances (30).
In conclusion, long-term adherence rates in MAA 
therapy of mild-to-moderate OSA patients is lower 
than those reported in short-term studies and younger 
patients show higher compliance rates. Since oral appli-
ance therapy is the first-line of treatment for a number 
of these patients, factors affecting adherence should be 
explored in future studies. Furthermore, interventions 
aimed at improving adherence should be designed to 
ensure the successful treatment of this chronic disease.
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